Results

eNauka >  Results >  Phase II Trial of HER-Vaxx, a B-cell Peptide-Based Vaccine, in HER2-Overexpressing Advanced Gastric Cancer Patients Under Platinum-Based Chemotherapy (HERIZON)
Title: Phase II Trial of HER-Vaxx, a B-cell Peptide-Based Vaccine, in HER2-Overexpressing Advanced Gastric Cancer Patients Under Platinum-Based Chemotherapy (HERIZON)
Authors Tobias, Joshua; ...; Andric, Zoran G  ; ...; Nikolic, Ivan  ; Petrovic, Zoran; ...; (broj, koautora 17)
Issue Date: 2024
Publication: CLINICAL CANCER RESEARCH
ISSN: 1078-0432 Clinical Cancer Research Search Idenfier
Type: Article
Collation: vol. 30 br. 18 str. 4044-4054
DOI: 10.1158/1078-0432.CCR-24-0742
WoS-ID: 001389386500010
Scopus-ID: 2-s2.0-85204164279
PMID: 39028916
PMCID: PMC11393538
URI: https://enauka.gov.rs/handle/123456789/961396
Project: Imugene Ltd.
Metadata source: (Preuzeto iz Nasi u WoS)
M-category: 
21a+M21a+

19
SCOPUSTM
15
PubMed CentralTM
18
WEB OF SCIENCETM
Altmetric
Dimensions
Unpaywall

Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.